Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation

Por Ropponen, K, Kellokoski, J, Pirinen, R, Moisio, K, Eskelinen, M, Alhava, E, Kosma, V
Publicado em 2001

Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma.

Por Hirvikoski, P, Kellokoski, J K, Kumpulainen, E J, Virtaniemi, J A, Johansson, R T, Kosma, V M
Publicado em 1999

Expression of transcription factor AP-2α predicts survival in epithelial ovarian cancer

Por Anttila, M A, Kellokoski, J K, Moisio, K I, Mitchell, P J, Saarikoski, S, Syrjänen, K, Kosma, V-M
Publicado em 2000

p21(WAF1) expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis

Por Pellikainen, M J, Pekola, T T, Ropponen, K M, Kataja, V V, Kellokoski, J K, Eskelinen, M J, Kosma, V-M
Publicado em 2003

p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis

Por Ropponen, K M, Kellokoski, J K, Lipponen, P K, Pietiläinen, T, Eskelinen, M J, Alhava, E M, Kosma, V-M
Publicado em 1999

Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study

Por Pukkila, M J, Kosunen, A S T, Virtaniemi, J A, Kumpulainen, E J, Johansson, R T, Kellokoski, J K, Nuutinen, J, Kosma, V-M
Publicado em 2004

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma

Por Karjalainen, J M, Kellokoski, J K, Mannermaa, A J, Kujala, H E, Moisio, K I, Mitchell, P J, Eskelinen, M J, Alhava, E M, Kosma, V M
Publicado em 2000